Fiera Capital (Canada)
TERN

Fiera Capital (Canada)’s Terns Pharmaceuticals TERN Stock Holding History

Fiera Capital (Canada)’s Portfolio TERN Stock Details TERN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-711,326
Closed -$37.5M – 428
2026
Q1 		$37.5M Buy
+711,326
New +$29.2M 0.13% 136

Other funds holding TERN

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Fiera Capital (Canada)'s TERN Position: Q2 2026 in Review

Fiera Capital (Canada) sold out of Terns Pharmaceuticals (TERN) in Q2 2026, closing a stake of 711,326 shares — an estimated $37.5M sold.

Fiera Capital (Canada) first reported a position in TERN in Q1 2026 and held it in 1 quarter. The position peaked at $37.5M in Q1 2026. 1 fund tracked by Wall St. Rank holds TERN as of Q2 2026.

  • Fiera Capital (Canada) reported no remaining Terns Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Fiera Capital (Canada) sold 711,326 Terns Pharmaceuticals shares in Q2 2026, an estimated $37.5M.
  • Fiera Capital (Canada) first reported a position in Terns Pharmaceuticals in Q1 2026 and held it in 1 quarter.
  • Fiera Capital (Canada)'s Terns Pharmaceuticals position peaked at $37.5M in Q1 2026.
  • 1 fund tracked by Wall St. Rank held Terns Pharmaceuticals as of Q2 2026.

Based on Fiera Capital (Canada)'s 13F filing for Q2 2026, filed 7 Aug 2026.